Metraipolis › archive › dc_db43b496add5
The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials — Europe PMC PMID:42179170
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42179170
- DOI
- 10.1192/bjo.2026.12001
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T06:28:54.177Z
- SHA-256 of the archived text
0568f17a9f4c75bc3f59c322f2a04e1ca331faaafb72bc8e23429e6485281440- Stable URL of this page
https://metraipolis.com/documento/dc_db43b496add5
How to cite
The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials — Europe PMC PMID:42179170 — Europe PMC (en), https://europepmc.org/article/MED/42179170 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db43b496add5 (Metraipolis archive dc_db43b496add5, sha256 0568f17a9f4c75bc3f59c322f2a04e1ca331faaafb72bc8e23429e6485281440)
BibTeX
@misc{dcdb43b496add5,
title = {The safety and efficacy of semaglutide in people with schizophrenia spectrum disorders: systematic review and meta-analysis of randomised controlled trials — Europe PMC PMID:42179170},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42179170},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db43b496add5; sha256 0568f17a9f4c75bc3f59c322f2a04e1ca331faaafb72bc8e23429e6485281440},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42179170. Agents can read the archived copy with the MCP tool read_document.